IGC Pharma EBITDA Margin (Quarterly) Analysis

IGC Pharma, Inc. (IGC)

0.2602 0.00 (0.00%) USD | NYAM | Feb 20, 16:00

0.265 0.00 (0.00%) After-Hours: 20:00

EBITDA Margin (Quarterly) Chart

View EBITDA Margin (Quarterly) for IGC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EBITDA Margin (Quarterly) Chart

Start Trial

Historical Data

View Historical Data

Start Trial

EBITDA Margin Definition

View EBITDA Margin Definition

Start Trial

EBITDA Margin (TTM) is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.

Read full definition.

EBITDA Margin (Quarterly) Range, Past 5 Years

View EBITDA Margin (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

EBITDA Margin (Quarterly) Benchmarks

View EBITDA Margin (Quarterly) Benchmarks

Start Trial

ACADIA Pharmaceuticals, Inc.	Upgrade
Agenus, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	--
Arrowhead Pharmaceuticals, Inc.	Upgrade